Como tratar corretamente a candidíase vulvovaginal recorrente?
Vídeo informativo sobre o panorama atual e a carga da candidíase vulvovaginal recorrente, bem como as abordagens de tratamento.
Referências:
• Yano J, Sobel JD, Nyirjesy P, et al. Current patient perspectives of vulvovaginal candidiasis: incidence, symptoms, management and post-treatment outcomes. BMC Womens Health. 2019;19(1):48.
• Denning DW, Kneale M, Rautemaa-Richardson R, Sobel JD. Global prevalence of recurrent and chronic vulvovaginal candidiasis. ESCMID, 2018. [on line] Available at: https://www.escmid.org/escmid_publications/escmid_elibrary/material/?mid...
• Aballéa S, Guelfucci F, Wagner J, et al. Subjective health status and health-related quality of life among women with Recurrent Vulvovaginal Candidosis (RVVC) in Europe and the USA. Health Qual Life Outcomes. 2013;11:169.
• Lírio J, Giraldo PC, Amaral RL, et al. Antifungal (oral and vaginal) therapy for recurrent vulvovaginal candidiasis: a systematic review protocol. BMJ Open. 2019;9(5):e027489.
• Tiran-Saucedo J, Garza H, Leon Y, Godinez-Burgos JA. The Search for Vaginal Candida Resistant Infections, A Descriptive Study [15R]. American College of Obstetricians and Gynecologists Annual Clinical and Scientific Meeting. 2019; 133 (suppl 5):195s.
• Sheary B, Dayan L. Recurrent vulvovaginal candidiasis. Aust Fam Physician. 2005;34(3):147-150.
• Belayneh M, Sehn E, Korownyk C. Recurrent vulvovaginal candidiasis. Canadian Family Physician. 2017; 63: 455.
• CDC. Fungal Diseases. Antifungal Resistance. 2018 [online] Available at: https://www.cdc.gov/fungal/antifungal-resistance.html
PP-PFE-BRA-2322